Case Report
BibTex RIS Cite

Digoxin’s Interactions with Various Drugs and A Case Report

Year 2021, Volume: 3 Issue: 2, 39 - 42, 15.12.2021
https://doi.org/10.51262/ejtox.879398

Abstract

Digoxin is a drug commonly used to achieve rate control in heart failure and atrial fibrillation with some form of arrhythmia. It shows a positive inotropic effect by inhibiting the Na + / K + ATPase pump in the myocardial cell membrane. Since digoxin is a drug with a narrow therapeutic range, the therapeutic dose range should be monitored and the individual dose regimen should be established, taking care of plasma concentrations. Factors such as patient's age, renal dysfunction, abnormal electrolyte values, drug-drug or drug-plant interactions increase the risk of intoxication. Patients may present with nausea and vomiting in digoxin intoxication and may present with ventricular arrhythmias with fatal rhythm disorders. Although digoxin should be discontinued as treatment, accompanying electrolyte imbalances should be treated. In patients with malignant arrhythmias, digoxin-specific antibodies should be considered in treatment. In this review, various drug-drug interactions that are frequently observed and easily prevented in patients taking digoxin are discussed with a case report.

Supporting Institution

There is no supporting institution

Project Number

No.

Thanks

We also thank Hafize Tan.

References

  • 1) Şahinoğlu AH. Yoğun Bakım Sorunları ve Tedavileri. Nobel Tıp Kitapevleri, İstanbul, 2011:2002-2015.
  • 2) Tekelioglu UY, Ayhan SS, Demirhan A, Ozturk S, Akkaya A, Yildiz I, et al. Digoxin Intoxication. Journal of Cardio-Vascular-Thoracic Anaesthesia and Intensive Care Society 2012;17(3):74-76. doi: 10.5222/gkdad.2011.074.
  • 3) Kayaalp SO. Rasyonel Tedavi Yönünden Tıbbi Farmakoloji. Hacettepe Taş, Ankara, 2002:529.
  • 4) Adalet K. Klinik Kardiyoloji Tanı ve Tedavi. İstanbul Tıp Kitabevi, İstanbul, 2013:221-225.
  • 5) Punniyakotti S, N BB. A Case Report on Digoxin Intoxication in a Clinical Pharmacist’s Perspective. Asian Journal of Pharmaceutical and Clinical Research 2018; 11(4):1-3.
  • 6) Emerk K, editor Tietz Laboratuvar Testleri Klinik Kılavuzu. Ankara: Güneş Tıp Kitabevleri; 2011.
  • 7) https://www.rxlist.com/lanoxin-tablets-drug.htm#interactions.
  • 8) HİSAR İ, ed. Kardiyolojide Klinik Problemler El Kitabı - Özetlenmiş Anahtar Referanslar İle. Bilimsel Tıp Yayınevi, Ankara, 1995.
  • 9) https://www.standardprocess.com/MediHerb-Document-Library/Catalog-Files/herb-drug-interaction-chart.pdf.
  • 10) Pita-Fernandez S, Lombardia-Cortina M, Orozco-Veltran D, Gil-Guillen V. Clinical manifestations of elderly patients with digitalis intoxication in the emergency department. Arch Gerontol Geriatr 2011;53(2):106-10.
  • 11) Çiftçi E, Aydın S. Toxicological Evaluation of Digital Glycosides in Congestive Heart Failure. Fabad Journal of Pharmaceutical Sciences 2018;43(3):263-77.

Digoxin’s Interactions with Various Drugs and A Case Report

Year 2021, Volume: 3 Issue: 2, 39 - 42, 15.12.2021
https://doi.org/10.51262/ejtox.879398

Abstract

Digoksin, kalp yetmezliğinde ve bir çeşit ritim bozukluğu olan atriyal fibrilasyonda hız kontrolü sağlamak için sık kullanılan bir ilaçtır. Miyokard hücre membranında bulunan Na+/K+ ATPaz pompasının inhibisyonu sonucu pozitif inotropik etki gösterir. Digoksin, dar terapötik aralığa sahip bir ilaç olduğu için plazma konsantrasyonlarına dikkat edilerek tedavi edici doz aralığı izlenmeli ve bireysel doz rejimi oluşturulmalıdır. Hastanın yaşı, böbrek fonksiyon bozuklukları, anormal elektrolit değerleri, ilaç-ilaç ya da ilaç-bitki etkileşimleri gibi faktörler intoksikasyon riskini artırmaktadır. Hastalar digoksin intoksikasyonunda bulantı-kusma ile başvuracakları gibi, ölümcül ritim bozuklukları olan ventriküler aritmilerle de başvurabilirler. Tedavi olarak öncelikle digoksinin kesilmesi gerekmekle birlikte hastanın eşlik eden elektrolit dengesizlikleri tedavi edilmelidir. Hastalarda malign aritmiler bulunması durumunda digoksine spesifik antikorlar tedavide düşünülmelidir. Bu derlememizde, digoksin kullanan hastalarda sık gözlenen ve kolay önlenebilen çeşitli ilaç-ilaç etkileşimleri bir olgu sunumu ile tartışılmıştır.

Project Number

No.

References

  • 1) Şahinoğlu AH. Yoğun Bakım Sorunları ve Tedavileri. Nobel Tıp Kitapevleri, İstanbul, 2011:2002-2015.
  • 2) Tekelioglu UY, Ayhan SS, Demirhan A, Ozturk S, Akkaya A, Yildiz I, et al. Digoxin Intoxication. Journal of Cardio-Vascular-Thoracic Anaesthesia and Intensive Care Society 2012;17(3):74-76. doi: 10.5222/gkdad.2011.074.
  • 3) Kayaalp SO. Rasyonel Tedavi Yönünden Tıbbi Farmakoloji. Hacettepe Taş, Ankara, 2002:529.
  • 4) Adalet K. Klinik Kardiyoloji Tanı ve Tedavi. İstanbul Tıp Kitabevi, İstanbul, 2013:221-225.
  • 5) Punniyakotti S, N BB. A Case Report on Digoxin Intoxication in a Clinical Pharmacist’s Perspective. Asian Journal of Pharmaceutical and Clinical Research 2018; 11(4):1-3.
  • 6) Emerk K, editor Tietz Laboratuvar Testleri Klinik Kılavuzu. Ankara: Güneş Tıp Kitabevleri; 2011.
  • 7) https://www.rxlist.com/lanoxin-tablets-drug.htm#interactions.
  • 8) HİSAR İ, ed. Kardiyolojide Klinik Problemler El Kitabı - Özetlenmiş Anahtar Referanslar İle. Bilimsel Tıp Yayınevi, Ankara, 1995.
  • 9) https://www.standardprocess.com/MediHerb-Document-Library/Catalog-Files/herb-drug-interaction-chart.pdf.
  • 10) Pita-Fernandez S, Lombardia-Cortina M, Orozco-Veltran D, Gil-Guillen V. Clinical manifestations of elderly patients with digitalis intoxication in the emergency department. Arch Gerontol Geriatr 2011;53(2):106-10.
  • 11) Çiftçi E, Aydın S. Toxicological Evaluation of Digital Glycosides in Congestive Heart Failure. Fabad Journal of Pharmaceutical Sciences 2018;43(3):263-77.
There are 11 citations in total.

Details

Primary Language English
Subjects Emergency Medicine
Journal Section Case Reports
Authors

Fatma Şengül 0000-0002-7097-6266

Muhammed Ulvi Yalcin 0000-0003-3750-8011

Hüsamettin Vatansev 0000-0002-0230-3414

Hakan Çomaklı 0000-0003-3771-4245

Project Number No.
Publication Date December 15, 2021
Submission Date February 13, 2021
Published in Issue Year 2021 Volume: 3 Issue: 2

Cite

APA Şengül, F., Yalcin, M. U., Vatansev, H., Çomaklı, H. (2021). Digoxin’s Interactions with Various Drugs and A Case Report. Eurasian Journal of Toxicology, 3(2), 39-42. https://doi.org/10.51262/ejtox.879398
AMA Şengül F, Yalcin MU, Vatansev H, Çomaklı H. Digoxin’s Interactions with Various Drugs and A Case Report. Eurasian J Tox. December 2021;3(2):39-42. doi:10.51262/ejtox.879398
Chicago Şengül, Fatma, Muhammed Ulvi Yalcin, Hüsamettin Vatansev, and Hakan Çomaklı. “Digoxin’s Interactions With Various Drugs and A Case Report”. Eurasian Journal of Toxicology 3, no. 2 (December 2021): 39-42. https://doi.org/10.51262/ejtox.879398.
EndNote Şengül F, Yalcin MU, Vatansev H, Çomaklı H (December 1, 2021) Digoxin’s Interactions with Various Drugs and A Case Report. Eurasian Journal of Toxicology 3 2 39–42.
IEEE F. Şengül, M. U. Yalcin, H. Vatansev, and H. Çomaklı, “Digoxin’s Interactions with Various Drugs and A Case Report”, Eurasian J Tox, vol. 3, no. 2, pp. 39–42, 2021, doi: 10.51262/ejtox.879398.
ISNAD Şengül, Fatma et al. “Digoxin’s Interactions With Various Drugs and A Case Report”. Eurasian Journal of Toxicology 3/2 (December 2021), 39-42. https://doi.org/10.51262/ejtox.879398.
JAMA Şengül F, Yalcin MU, Vatansev H, Çomaklı H. Digoxin’s Interactions with Various Drugs and A Case Report. Eurasian J Tox. 2021;3:39–42.
MLA Şengül, Fatma et al. “Digoxin’s Interactions With Various Drugs and A Case Report”. Eurasian Journal of Toxicology, vol. 3, no. 2, 2021, pp. 39-42, doi:10.51262/ejtox.879398.
Vancouver Şengül F, Yalcin MU, Vatansev H, Çomaklı H. Digoxin’s Interactions with Various Drugs and A Case Report. Eurasian J Tox. 2021;3(2):39-42.

Dizinler ve Platformlar

14707   14765   15059  20298 23132